Back to search
Mild and Moderate Atopic Dermatitis Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mild and Moderate Atopic Dermatitis Patients trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Mild and Moderate Atopic Dermatitis Patients trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an exploratory, proof-of-concept, double-blind, placebo-controlled, randomized, comparative, interventional, prospective, safety in-use tolerability and…
Elidel® is indicated for the short-term treatment and long-term management of signs and symptoms of atopic dermatitis (AD) in infants (3 to 23 months), children…